Soft Tissue Neoplasms
Soft Tissue Neoplasms
Definition
Soft Tissue: All non-epithelial tissue arising from mesodermal derivatives, excluding:
Bone
Cartilage
Brain and coverings
Hematopoietic cells
Lymphoid tissue
Classification
1. Benign Tumors (more common)
Adipose Tissue: Lipoma
Fibrous Tissue: Keloid, Fibroma, Nodular Fasciitis
Fibrohistocytic: Fibrous histiocytoma
Muscle Origin: Rhabdomyoma, Leiomyoma
Lymphatic System: Cystic hygroma, Lymphangioma simplex, Lymphangioma
Vascular System: Hemangioma, Pyogenic granuloma, Glomus body tumor
Nervous System: Neuroma, Neurofibroma, Schwannoma
Uncertain Origin: Hamartoma
2. Locally Malignant Tumors (do not metastasize)
Desmoid tumor
Dermatofibrosarcoma protuberans
3. Malignant Tumors (rare)
Liposarcoma
Fibrosarcoma
Malignant fibrous histiocytoma
Rhabdomyosarcoma
Leiomyosarcoma
Lymphangiosarcoma
Hemangiosarcoma
Malignant Schwannoma
Kaposi sarcoma
Malignant hamartoma
Synovial sarcoma
Epithelioid sarcoma
Benign Tumors Details
Lipoma
Common soft tissue neoplasm, can occur anywhere with adipose tissue (excludes eyelids, glans penis).
Common sites include head & neck, shoulder, abdominal wall, thighs.
Usually solitary; can be familial (Dercum disease).
Types of Lipoma
Pathological: Pure lipoma, fibrolipoma, hemangiolipoma, angiolipoma (painful).
Anatomical: (in decreasing frequency)
Subcutaneous
Inter-muscular
Retroperitoneal
Sub-fascial
Sub-serous
Sub-mucous
Sub-synovial
Intra-articular
Para-osteal
CNS
Intra-glandular
Clinical Picture
History: Slowly growing, painless lump.
Examination: Well-defined, smooth/lobulated surface, non-tender, soft, mobile, pseudo-fluctuant.
Investigations: FNAC shows benign fat cells; US shows well-circumscribed, capsulated swelling.
Differential Diagnosis: Sebaceous cyst, fibroma, organized hematoma, ganglion.
Complications
Sarcomatous changes in specific sites (retroperitoneal, back, thigh)
Myxomatous degeneration
Calcification
Pressure effects
Treatment
Standard: Excisional biopsy; Liposuction for cosmetic cases.
For multiple tumors: Excise symptomatic/complicating one.
Fibroma
Rare as pure fibroma; usually combined types: fibromyoma, fibrolipoma, etc.
Soft or hard based on proportion of fibrous to cellular tissue.
Neurofibromatosis
Genetics: Autosomal dominant (AD).
Types:
Type 1: Von Recklinghausen disease; characterized by multiple pedunculated nodules & café-au-lait spots.
Type 2: Bilateral acoustic neurofibromatosis; presents with pain, numbness, tenderness along nerve axis.
Local Malignant Tumors
Desmoid Tumor
Rare tumor from musculo-aponeurotic tissues.
Most common site: Anterior abdominal wall, presents as hard mass.
Associated with familial polyposis coli (Gardner syndrome).
Pathology
Fibrous tissue structure, multinucleated, un-capsulated; infiltrates surrounding muscles.
No metastasis or sarcomatous change.
Treatment
Wide excision with safety margins; repair muscular defects with prosthetic mesh.
Radiotherapy for adjuvant therapy.
Dermatofibrosarcoma Protuberans
Intermediate tumor between benign and malignant.
Composed of fibroblasts and lipid-laden phagocytes.
Clinical Picture: Rare, occurs in young individuals, presents as bluish dermal nodule; sudden growth, ulceration possible.
Treatment: Wide local excision.
Soft Tissue Sarcomas (STS)
Rare (1% of human cancers), arise from mesenchymal tissue.
Histological grading & clinical staging are significant for prognosis.
Characteristics
Younger age; rapid growth; higher local invasion; common blood-borne metastasis; worse prognosis.
Etiology
Unknown, but include:
Radiation exposure
Post-mastectomy lymphedema
Von Recklinghausen disease
Grading
G1: Well differentiated
G2: Moderately differentiated
G3: Poorly differentiated
G4: Undifferentiated
Staging
T1: ≤ 5 cm
T2: > 5 cm
N0: No regional LN metastasis
N1: Regional LN metastasis
M0: No distant metastasis
M1: Distant metastasis
Differential Diagnosis
Benign tumors, hematoma, vascular issues, lymphadenopathy, myositis ossificans.
Prognostic Factors
Tumor type: Malignant histiocytoma is the worst.
Grading: Undifferentiated is worse.
Staging: Distant metastases are often fatal.
Site: Retroperitoneal is more fatal.
Local recurrence: Recurrence predisposes further recurrences.
Biological expression of tumor (e.g., p53).
Clinical Picture of STS
Rapidly growing, painless swelling, hot surface, ill-defined borders, fixed structure, variable consistency.
Investigations
CT: Best for abdominal/thoracic lesions
MRI: Better for neurological/muscle lesions
PET: Evaluates metabolic functions
Biopsy: Open incisional or FNAC/cored biopsy under imaging guidance preferred.
Treatment
Surgical: En-bloc wide excision including major neurovascular structures if needed. Amputation for aggressive cases. Localized solitary metastases could be excised.
Radiotherapy: Preoperative reduces size; postoperative adjuvant for suspected margin involvement.
Chemotherapy: Best results in childhood malignancies.
Characterization of Specific Tumors
Liposarcoma: Most common, occurs in ages 50-60, frequent in retroperitoneal region.
Malignant Fibrohistosarcoma: Common in young adults, highly aggressive, >50% recurrence/metastasis rate.
Fibrosarcoma: 2nd most common in 35-50 years; firm, rubbery, painless lump, variable grades.
Rhabdomyosarcoma: Predominantly in children, good response to treatments.
Kaposi Sarcoma: Rare malignancy with skin lesions; two types based on aggressiveness; treatment includes AZT/IFN and limited surgery.
Synovial Sarcoma: Comprises 10% of STS, originates from mesenchymal cells; high grade indicates aggressive nature with high recurrence rate.
Retroperitoneal Tumors
Anatomy
Retroperitoneal space: Extends from diaphragm to pelvic brim, contains various vital organs and vasculature.
Classification
Cystic: Teratoma, others.
Solid benign (20%): Lipoma, others.
Malignant (80%): Lymphoma, liposarcoma, fibrosarcoma.
Diagnosis
Symptoms include abdominal discomfort, back pain, fatigue.
Examination may reveal palpable mass causing vascular obstructions.
Imaging: CT/MRI as primary tools; CT-guided biopsy essential.
Treatment
Surgical excision is standard, but few are resectable. In unresectable cases, de-bulking and combined treatment offer better prognosis than either alone.